胞嘧啶市場規模、佔有率、趨勢分析報告：按最終用途、按地區、細分市場預測，2024-2030 年

胞嘧啶市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球胞嘧啶市場規模將達到6.5481億美元，預計2024年至2030年複合年成長率為9.6%。

這一成長歸因於產品廣泛應用於製藥、農業和化學品等最終用途行業的各種應用。製藥業是市場的主要最終用戶。胞嘧啶是一種核苷酸鹼基，用於合成各種藥物，包括抗病毒藥物、抗癌藥物和核苷類似物。該行業對基因組學和個人化醫療的關注進一步增加了產品需求。

基因組研究需要分析DNA序列，而胞嘧啶則是構成DNA的四種核苷酸鹼基之一。胞嘧啶在基因組序列測定和分析中發揮關鍵作用，對於闡明遺傳變異和開發標靶治療至關重要。全球工業提供了探索新應用並最佳化自身及其衍生物性能的研發機會。正在進行的研究可以集中在提高類似物的功效、生物有效性和安全性，從而改善愛滋病毒/愛滋病患者的治療選擇。此外，可以進行研究以探索應用於聯合治療和新的藥物傳輸系統的可能性。對中間體產品的需求正在上升，特別是在個人化醫療和基因檢測領域。

需求的增加可能會導致胞嘧啶價格上漲。由於該產品的多功能性和效用，以及對創新藥物不斷成長的需求，它被用於針對多種疾病和健康狀況的藥物開發的複雜過程中。農業部門主要圍繞其他核苷酸鹼基在農業應用中的利用。胞嘧啶在作物改良和育種計劃中發揮重要作用。胞嘧啶和其他核苷酸鹼基的遺傳變異和突變對於傳統作物育種至關重要，可以開發出具有抗病性、產量增加和營養成分增強等理想性狀的改良作物品種。

胞嘧啶市場報告亮點

• 由於胞嘧啶在核酸療法開發中的重要作用，藥品將成為成長最快的最終用途領域，2024 年至 2030 年的複合年成長率為 9.8%。
• 由於製藥和化學品等成熟的終端用戶產業的存在，預計歐洲從 2024 年到 2030 年的複合年成長率將達到 10.3%。
• 胞嘧啶是植物性因體學和分子生物學研究的基本要素。植物科學家使用胞嘧啶和其他核苷酸鹼基來研究植物性因的結構、功能和相互作用。
• 產品的消費受到各種政策的約束和必須遵循的政策。主要法規包括衛生和植物檢疫措施（SPS）協議、智慧財產權（IPR）以及定價和報銷政策。在某些情況下，這些法規和政策可能會阻礙產業發展。
• 圍繞著產品的使用，尤其是針對各種疾病的藥物合成，正在發生許多創新。
• 例如，2023 年 1 月，專門從事 DNA序列測定技術的英國公司 Cambridge 磊晶最近更名為 Biomodal。作為品牌重塑的一部分，該公司宣布推出新產品，提供簡化的定序工作流程，可以捕捉 DNA 內的遺傳和磊晶資訊。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 胞嘧啶：市場變數、趨勢、範圍

• 市場體系展望
  • 全球核苷酸市場展望
• 產業價值鏈分析
  • 原料趨勢
  • 製造業趨勢
  • 技術評估
  • 潛在最終用戶列表
• 2023 年全球生產成本分析
• 成本結構分析，2023年（%）
• 法律規範（標準和合規性、核准、政策）
• 2018-2030年價格趨勢分析
• 市場動態
  • 市場促進因素分析
  • 市場抑制因素分析
  • 市場問題分析
  • 市場機會分析
• 產業分析工具
  • 波特的分析
  • 宏觀經濟分析PESTLE分析

第4章 胞嘧啶市場：最終用途估計與趨勢分析

• 2023 年和 2030 年最終用途變化分析和市場佔有率
  • 化學工業
  • 藥品
  • 農業
  • 其他最終用途

第5章 胞嘧啶市場：區域估計與趨勢分析

• 胞嘧啶市場：區域展望
• 北美洲
  • 2018-2030 年北美胞嘧啶市場估計與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 2018-2030 年歐洲胞嘧啶市場估計與預測
  • 德國
  • 英國
  • 法國
• 亞太地區
  • 2018-2030 年亞太地區胞嘧啶市場估計與預測
  • 中國
  • 印度
  • 日本
• 中美洲和南美洲
  • 2018-2030 年拉丁美洲胞嘧啶市場估計與預測
• 中東和非洲
  • 中東和非洲胞嘧啶市場估計和預測，2018-2030

第6章競爭形勢

• 公司分類
• 2023年公司市場定位分析
• 企業熱力圖分析
• 策略規劃
• 公司名單（業務概況、財務表現、產品系列）
  • Spectrum Chemical
  • Tuoxin Pharmaceutical
  • VIVAN Life Sciences
  • KANTO KAGAKU
  • Tokyo Chemical Industry Co., Ltd.
  • SIELC Technologies
  • Santa Cruz Biotechnology, Inc.
  • FUJIFILM Wako Pure Chemical Corporation

Cytosine Market Growth & Trends:

The global cytosine market size is estimated to reach USD 654.81 million by 2030, and is expected to grow at a CAGR of 9.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to the extensive product usage in various applications in end-use industries, such as pharmaceuticals, agriculture, and chemicals. The pharmaceutical industry is a major end-user of the market. Cytosine is a nucleotide base, which is utilized in the synthesis of various pharmaceutical products, including antiviral drugs, anticancer agents, and nucleoside analogues. The emphasis on genomics and personalized medicine within the industry has further increased product demand.

Genomic research requires the analysis of DNA sequences, and it is one of the four nucleotide bases that make up DNA. Cytosine's role in genomic sequencing and analysis makes it indispensable for understanding genetic variations and developing targeted therapies. The global industry presents opportunities for R&D to explore new applications and optimize the properties of itself as well as its derivatives. Ongoing research can focus on enhancing the efficacy, bioavailability, and safety profiles of its analogs, leading to improved treatment options for HIV/AIDS patients. In addition, research can explore its potential use in combination therapies and novel drug delivery systems. The product demand as an intermediate has been on the rise, particularly in the field of personalized medicine and genetic testing.

This growing demand can contribute to upward pressure on the prices of cytosine. Versatile nature and utility of the product, as well as rising demand for innovative pharmaceuticals, has led to it being used in intricate processes in drug development directed toward varied ailments and health conditions. The agriculture segment primarily revolves around utilizing other nucleotide bases in agricultural applications. Cytosine plays a crucial role in crop improvement and breeding programs. Genetic variations and mutations in cytosine and other nucleotide bases are essential for traditional crop breeding, allowing the development of improved crop varieties with desirable traits, such as disease resistance, increased yield, and enhanced nutritional content.

Cytosine Market Report Highlights:

• Pharmaceuticals will emerge as the fastest-growing end-use segment with a CAGR of 9.8% from 2024 to 2030 due to cytosine's crucial role in the development of nucleic acid-based therapeutics
• Europe is expected to register the fastest CAGR of 10.3% from 2024 to 2030 due to the presence of well-established end-user industries, such as pharmaceuticals and chemicals
• Cytosine is a fundamental component in plant genomics and molecular biology research. Plant scientists utilize cytosine and other nucleotide bases to study the structure, function, and interactions of plant genes
• The product consumption is subjected to various policies/regulations that need to be followed. Some of the major regulations are Sanitary and Phytosanitary Measures (SPS) Agreement, Intellectual Property Rights (IPR), and Pricing and Reimbursement policies. In some cases, these policies/regulations pose a challenge to industry growth
• Numerous innovations are taking place that revolve around product usage, especially for the synthesis of drugs targeting various ailments
• For example, in January 2023, Cambridge Epigenetix, a UK-based company specializing in DNA sequencing technology, recently underwent rebranding and is now known as Biomodal. As a part of this rebranding, the company has launched a new product that offers a streamlined sequencing workflow capable of capturing both genetic & epigenetic information within DNA

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation & Scope
• 1.2 Market Definition
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
• 1.4 Information analysis
• 1.5 Market formulation & data visualization
• 1.6 Data validation & publishing
  • 1.6.1 Research scope and assumptions
  • 1.6.2 List of Data Sources

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Cytosine: Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Global Nucleotide Market Outlook
• 3.2 Industry Value Chain Analysis
  • 3.2.1 Raw Material Trends
  • 3.2.2 Manufacturing Trends
  • 3.2.3 Technology Assessment
  • 3.2.4 List of Potential End-users
• 3.3 Global Production Cost Analysis, 2023 (USD/kg)
• 3.4 Cost Structure Analysis, 2023 (%)
• 3.5 Regulatory Framework (Standards and Compliances, Approvals, Policies)
• 3.6 Price Trend Analysis, 2018-2030 (USD/Kg)
• 3.7 Market Dynamics
  • 3.7.1 Market Driver Analysis
  • 3.7.2 Market Restraint Analysis
  • 3.7.3 Market Challenge Analysis
  • 3.7.4 Market Opportunities Analysis
• 3.8 Industry Analysis Tools
  • 3.6.1 PORTERs Analysis
  • 3.6.2 Macroeconomic Analysis- PESTLE Analysis

Chapter 4 Cytosine Market: End-use Estimates & Trend Analysis

• 4.1 End-use Movement Analysis & Market Share, 2023 & 2030
  • 4.1.1 Chemical Industry
  • 4.1.2 Pharmaceutical
  • 4.1.3 Agriculture
  • 4.1.4 Other End-uses

Chapter 5 Cytosine Market: Regional Estimates & Trend Analysis

• 5.1 Cytosine Market: Regional Outlook
• 5.2 North America
  • 5.2.1 North America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.2.2 U.S.
    • 5.2.2.1 Key Country Dynamics
    • 5.2.2.2 U.S. Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.2.3 Canada
    • 5.2.3.1 Key Country Dynamics
    • 5.2.3.2 Canada Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.2.4 Mexico
    • 5.2.4.1 Key Country Dynamics
    • 5.2.4.2 Mexico Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.3 Europe
  • 5.3.1 Europe Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.3.2 Germany
    • 5.3.2.1 Key Country Dynamics
    • 5.3.2.2 Germany Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.3.3 UK
    • 5.3.3.1 Key Country Dynamics
    • 5.3.3.2 UK Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.3.3 France
    • 5.3.3.1 Key Country Dynamics
    • 5.3.3.2 France Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.4.2 China
    • 5.4.2.1 Key Country Dynamics
    • 5.4.2.2 China Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.4.3 India
    • 5.4.3.1 Key Country Dynamics
    • 5.4.3.2 India Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
  • 5.4.4 Japan
    • 5.4.4.1 Key Country Dynamics
    • 5.4.4.2 Japan Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.5 Central & South America
  • 5.5.1 Central & South America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)

Chapter 6 Competitive Landscape

• 6.1 Company Categorization
• 6.2 Company Market Positioning Analysis, 2023
• 6.3 Company Heat Map Analysis
• 6.4 Strategy Mapping
• 6.5 Company Listing (Business Overview, Financial Performance, Product Portfolio)
  • 6.5.1 Spectrum Chemical
  • 6.5.2 Tuoxin Pharmaceutical
  • 6.5.3 VIVAN Life Sciences
  • 6.5.4 KANTO KAGAKU
  • 6.5.5 Tokyo Chemical Industry Co., Ltd.
  • 6.5.6 SIELC Technologies
  • 6.5.7 Santa Cruz Biotechnology, Inc.
  • 6.5.8 FUJIFILM Wako Pure Chemical Corporation

List of Tables

• Table 1 List of Key Raw Material Suppliers
• Table 2 List of Potential End Users
• Table 3 U.S. macro-economic outlay
• Table 4 U.S. macro-economic outlay
• Table 5 Mexico macro-economic outlay
• Table 6 Germany macro-economic outlay
• Table 7 UK macro-economic outlay
• Table 8 France macro-economic outlay
• Table 9 China macro-economic outlay
• Table 10 India macro-economic outlay
• Table 11 Japan macro-economic outlay
• Table 12 Recent Developments & Impact Analysis, By Key Market Participants
• Table 13 Participant's Overview
• Table 14 Financial Performance
• Table 15 Company Heat Map Analysis

List of Figures

• Fig. 1 Cytosine Market Segmentation & Scope
• Fig. 2 Information procurement
• Fig. 3 Data analysis models
• Fig. 4 Market formulation and validation
• Fig. 5 Data validation & publishing
• Fig. 6 Cytosine Market Snapshot
• Fig. 7 Cytosine Market Segment Snapshot
• Fig. 8 Cytosine Market Competitive Landscape Snapshot
• Fig. 9 Global Nucleotides and Cytosine Market Value, 2023 (USD Million)
• Fig. 10 Cytosine Market: Industry Value Chain Analysis
• Fig. 11 Cytosine Market: Price Trend Analysis, 2018 - 2030 (USD/Kg)
• Fig. 12 Cytosine Market Dynamics
• Fig. 13 Cytosine Market: PORTERs Analysis
• Fig. 14 Cytosine Market: PESTLE Analysis
• Fig. 15 Cytosine Market Share, By End-use, 2023 & 2030
• Fig. 16 Cytosine Market Estimates & Forecasts, in Chemical Industry, 2018-2030 (Tons) (USD Thousand)
• Fig. 17 Cytosine Market Estimates & Forecasts, in Pharmaceuticals, 2018-2030 (Tons) (USD Thousand)
• Fig. 18 Cytosine Market Estimates & Forecasts, in Agriculture, 2018-2030 (Tons) (USD Thousand)
• Fig. 19 Cytosine Market Estimates & Forecasts, in Other End-uses, 2018-2030 (Tons) (USD Thousand)
• Fig. 20 Cytosine Market Revenue, by Region, 2023 & 2030 (USD Thousand)
• Fig. 21 North America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 22 U.S. Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 23 Canada Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 24 Mexico Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 25 Europe Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 26 Germany Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 27 UK Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 28 France Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 29 Asia Pacific Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 30 China Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 31 India Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 32 Japan Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 33 Central & South America Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 34 Middle East & Africa Cytosine Market Estimates & Forecasts, 2018 - 2030 (Tons) (USD Thousand)
• Fig. 35 Key Company Categorization
• Fig. 36 Cytosine Market - Company Market Positioning Analysis - 2023
• Fig. 37 Strategic Mapping